Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health System

Fundación Pública Andaluza Progreso y Salud

Status: Unknown

Conditions: Carcinoma, Non-Small-Cell Lung

Study type: Observational

Funder types: Other

Identifiers

NCT01877902

FPS-PEM-2013-06

Details and patient eligibility

About

STUDY OF USE OF PEMETREXED IN PATIENTS WITH NON-SMALL LUNG CANCER METASTATIC IN ANDALUSIAN PUBLIC HEALTH SYSTEM

Enrollment: 190 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients over 18 years
• Confirmed diagnosis of metastatic NSCLC
• Pemetrexed Starts 1st line (either induction or maintenance) in any of the following periods:
• January 1, 2010 to March 31, 2010
• October 1, 2011 to December 31, 2011

Exclusion criteria

• Patients receiving pemetrexed within a clinical trial protocol because it is an experimental environment that does not reflect clinical practice.

Trial design

190 participants in 1 patient group

Pemetrexed 500 mg/m 2